Healthcare-Associated Infection & AMR
MoiM CPE Detection Kit


   Export-only Approval

Category

Intended Use

An in vitro diagnostic medical device intended to aid in the diagnosis of carbapenemase-producing Enterobacterales (CPE) infection by detecting carbapenemase resistance genes (KPC, NDM, and OXA-48-like) in genomic DNA extracted from rectal swab specimens collected from patients suspected of CPE infection, using multiplex real-time polymerase chain reaction (PCR) technology.

Target Genes

KPC, NDM, OXA-48

Sample Types

Rectal Swab 

Sample Volume

250 uL

LoD

KPC 9.26 x 10^1 CFU/mL 
NDM 6.63 x 10^0 CFU/mL 
OXA-48 3.32 x 10^1 CFU/mL

Target Specificity

(To be added after clinical trials)

Turnaround Time

70min